miR-429-CRKL axis regulates clear cell renal cell carcinoma malignant progression through SOS1/MEK/ERK/MMP2/MMP9 pathway

Biomed Pharmacother. 2020 Jul:127:110215. doi: 10.1016/j.biopha.2020.110215. Epub 2020 May 12.

Abstract

The pathogenesis and tumorigenesis of clear cell renal cell carcinoma (ccRCC) remain unclear. The deregulations of miR-429, a member of miR-200 family, and v-crk sarcoma virus CT10 oncogene homologue (avian)-like (CRKL), an adaptor protein of CRK family, are involved in the development, metastasis and prognosis of various cancers. Current study aimed to demonstrate the differential expressions of miR-429 and CRKL with their correlationship and molecular regulation mechanism in ccRCC malignancy. miR-429 and CRKL separately showed suppressing and promoting effects in ccRCC. Lower miR-429 expression and higher CRKL expression were negatively correlated in surgical cancerous tissues by promoting the advance of ccRCC. By binding to the 3'-UTR of CRKL, miR-429 reversely regulated CRKL for its functionalities in ccRCC cells. CRKL knockdown and overexpression separately decreased and increased the in vitro migration and invasion of 786-O cells, which were consistent with the influences of miR-429 overexpression and knockdown on 786-O through respectively downregulating and upregulating CRKL via SOS1/MEK/ERK/MMP2/MMP9 pathway. The enhancements of CRKL expression, migration and invasion abilities and SOS1/MEK/ ERK/MMP2/MMP9 activation induced by TGF-β stimulation in 786-O cells could be antagonized by miR-429 overexpression. Exogenous re-expression of CRKL abrogated miR-429 suppression on the migration and invasion of 786-O cells. Collectively, miR-429 deficiency negatively correlated with CRKL overexpression promoted the aggressiveness of cancer cells and advanced the clinical progression of ccRCC patients. miR-429-CRKL axial regulation provides new clues to the fundamental research, diagnosis and treatment of ccRCC.

Keywords: Clear cell renal carcinoma(ccRCC); MiR-429-CRKL axis; SOS1/MEK/ERK/MMP2/MMP9 pathway; Tumorigenesis.

MeSH terms

  • Adaptor Proteins, Signal Transducing / genetics*
  • Carcinoma, Renal Cell / genetics
  • Carcinoma, Renal Cell / pathology*
  • Cell Line, Tumor
  • Disease Progression
  • Down-Regulation
  • Female
  • Gene Knockdown Techniques
  • Humans
  • Kidney Neoplasms / genetics
  • Kidney Neoplasms / pathology*
  • MAP Kinase Signaling System
  • Male
  • Matrix Metalloproteinase 2 / metabolism
  • Matrix Metalloproteinase 9 / metabolism
  • MicroRNAs / genetics*
  • Middle Aged
  • Prognosis
  • SOS1 Protein / metabolism
  • Up-Regulation

Substances

  • Adaptor Proteins, Signal Transducing
  • CRKL protein
  • MIRN429 microRNA, human
  • MicroRNAs
  • SOS1 Protein
  • SOS1 protein, human
  • MMP2 protein, human
  • Matrix Metalloproteinase 2
  • MMP9 protein, human
  • Matrix Metalloproteinase 9